Planned Maintenance: Some services may turn out to be unavailable from 15th January, 2026 to 16th January, 2026. We apologize for the inconvenience!

4OAV image
Deposition Date 2014-01-06
Release Date 2014-03-12
Last Version Date 2023-09-20
Entry Detail
PDB ID:
4OAV
Keywords:
Title:
Complete human RNase L in complex with 2-5A (5'-ppp heptamer), AMPPCP and RNA substrate.
Biological Source:
Source Organism(s):
Homo sapiens (Taxon ID: 9606)
Expression System(s):
Method Details:
Experimental Method:
Resolution:
2.10 Å
R-Value Free:
0.22
R-Value Work:
0.19
R-Value Observed:
0.19
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polyribonucleotide
Molecule:RNA (5'-R(P*(PO4)P*(PO4)P*AP*AP*AP*AP*(PO4))-2')
Chain IDs:B (auth: A), D (auth: C)
Chain Length:7
Number of Molecules:2
Biological Source:
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:PROTEIN (RNase L)
Gene (Uniprot):RNASEL
Chain IDs:A (auth: B), C (auth: D)
Chain Length:699
Number of Molecules:2
Biological Source:Homo sapiens
Primary Citation
Structure of human RNase L reveals the basis for regulated RNA decay in the IFN response.
Science 343 1244 1248 (2014)
PMID: 24578532 DOI: 10.1126/science.1249845

Abstact

One of the hallmark mechanisms activated by type I interferons (IFNs) in human tissues involves cleavage of intracellular RNA by the kinase homology endoribonuclease RNase L. We report 2.8 and 2.1 angstrom crystal structures of human RNase L in complexes with synthetic and natural ligands and a fragment of an RNA substrate. RNase L forms a crossed homodimer stabilized by ankyrin (ANK) and kinase homology (KH) domains, which positions two kinase extension nuclease (KEN) domains for asymmetric RNA recognition. One KEN protomer recognizes an identity nucleotide (U), whereas the other protomer cleaves RNA between nucleotides +1 and +2. The coordinated action of the ANK, KH, and KEN domains thereby provides regulated, sequence-specific cleavage of viral and host RNA targets by RNase L.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback